全球體外診斷市場分析

全球體外診斷市場分析 是由出版商RNCOS E-Services Pvt. Ltd.在2011年12月所出版的。 這份英文市場調查報告書包含130 Pages 價格從美金1600起跳。

簡介

全球體外診斷市場在2011年在2013年之間，年複利成長率(年複合成長率)將以6％前後增長，到2013年年終將達到大約520億美元的市場規模。

本報告提供全球IVD(體外診斷)市場的相關調查，市場規模，推動市場的要素·阻礙要素，主要市場區隔與今後的預測，各地區市場，新興市場，競爭情形等分析，再加上主要企業簡介彙整，為您概述為以下內容。

第1章 分析師的見解

第2章 調查手法

第3章 體外診斷市場概要

• 簡介
• 體外診斷是什麼？
• 市場規模·成長

第4章 推動市場的要素

• 慢性疾病·感染疾病
• 新技術
• 新興市場
• 應用的多樣化
• 醫療保健的基本設備

第5章 治療的不同市場區隔預測:2013年

• 醫護站診斷
• 臨床化學·免疫化學
• 分子診斷學
• 微生物學
• 止血
• 血液學
• 免疫疾病血液學

第6章 各適應症各市場區隔(現狀及今後預測:∼2013年)

• 糖尿病
• 心臟血管
• 癌症
• HIV
• 結核
• 流感

第7章 各地區各市場區隔（現狀及今後預測:∼2013年)

• 北美
• 歐洲
• 日本
• 其他的主要各國

第8章 消費者態度分析

第9章 新興市場

• 搭配診斷/診斷科技
• 奈米診斷

第10章 最近的發展·收購與合併

第11章 市場阻礙成長要素

• 法規·費用回本的課題
• 研究開發及短期產品生命週期
• 成本管理

第12章 競爭情形

• 前幾名企業的市場佔有率
• 主要企業

圖表

目錄

Abstract

With the rapidly diversifying diagnostic industry, the In Vitro Diagnostic (IVD) has evolved as a major contributing segment. Extensive scientific research and development, technological advancements, and rising government and private sector participation are facilitating the growth globally. Demographic parameters, such as increasing disease prevalence and high disposable income have also contributed to the development of IVD services industry, which was estimated to have reached around US$ 43 Billion in 2010.

According to our new research report " Global In Vitro Diagnostic Market Analysis" , the global IVD market is likely to grow at a CAGR of around 6% during 2011-2013 to reach around US$ 52 Billion by 2013-end. The industry, which has been witnessing innovative healthcare and diagnostic solutions, is anticipated to continue striving towards technological innovation and widening its spectrum in all dimensions.

The report analyzes the key segments in the IVD market, which has witnessed tremendous growth in the recent years. The developments in the point-of-care and molecular diagnostics segment are also found to be high. The research also observes that the increasing prevalence of chronic diseases and rising technological R&D are fuelling growth in these segments. It also studies how the rising healthcare spending across the globe would impact these segments, which are likely to witness robust growth in revenues.

Our report provides a comprehensive geographic segmentation of the IVD market globally. Through top countries' profiles, the study elaborates the performance of the IVD market in these nations, key developments in recent times, and provides forecast for the industry. The developed countries have been performing well in the IVD industry, but a great potential also lies for the industry in developing countries.

The report finds that Companion Diagnostics and Nano-diagnostics are the emerging sectors in the IVD industry, in which the growth is being fuelled by extensive R&D and novel solutions. The report also discusses the profiles of the key players in the industry to provide an insight into the competitive landscape.

Table of Contents

1. Analyst View

2. Research Methodology

3. In Vitro Diagnostic Market Overview

• 3.1 Introduction
• 3.2 What is In Vitro Diagnostics?
• 3.3 Market Size and Growth

4. Market Drivers

• 4.1 Chronic and Infectious Diseases
• 4.2 New Technologies
• 4.3 Emerging Markets
• 4.4 Diversifying Applications
• 4.5 Healthcare Infrastructure

5. Clinical Segmentation Outlook 2013

• 5.1 Point-of-Care Diagnostics
• 5.2 Clinical Chemistry and Immunochemistry
• 5.3 Molecular Diagnostics
• 5.4 Microbiology
• 5.5 Hemostasis
• 5.6 Hematology
• 5.7 Immunohematology

6. Segmentation by Indication (Current & Future Scenario - 2013)

• 6.1 Diabetes
• 6.2 Cardiovascular
• 6.3 Cancer
• 6.4 HIV
• 6.5 Tuberculosis
• 6.6 Influenza

7. Geographical Segmentation (Current & Future Scenario - 2013)

• 7.1 North America
  • 7.1.1 United States
  • 7.1.2 Canada
• 7.2 Europe
  • 7.2.1 Germany
  • 7.2.2 France
  • 7.2.3 Italy
  • 7.2.4 United Kingdom
  • 7.2.5 Spain
  • 7.2.6 Other European Countries
• 7.3 Japan
• 7.4 Other Key Countries
  • 7.4.1 China
  • 7.4.2 India
  • 7.4.3 Turkey
  • 7.4.4 Brazil
  • 7.4.5 Mexico

8. Consumer Behavior Analysis

9. Emerging Sectors

• 9.1 Companion Diagnostics/Theranostics
• 9.2 Nanodiagnostics

10. Recent Developments and M&As

11. Industry Restraints

• 11.1 Regulatory and Reimbursement Issues
• 11.2 R&D and Short Product Lifecycle
• 11.3 Cost Control

12. Competitive Landscape

• 12.1 Market Share of Top Players
• 12.2 Key Players
  • 12.2.1 Roche Holding Ltd.
  • 12.2.2 Abbott Laboratories
  • 12.2.3 Siemens AG
  • 12.2.4 Beckman Coulter
  • 12.2.5 Ortho-Clinical Diagnostics

List of Figures:

• Figure 3-1: Global - In Vitro Diagnostic Market (Billion US$), 2008-2013
• Figure 5-1: Global - In Vitro Diagnostic Market by Clinical Segment (%), 2010
• Figure 5-2: Global - Forecast for In Vitro Diagnostic Market by Clinical Segment (%), 2013
• Figure 5-3: Global - Point of Care Diagnostic Market by Segment (%)
• Figure 5-4: Global - Point of Care Diagnostic Market by Distribution (%)
• Figure 5-5: Global - Point of Care Diagnostic Market (Billion US$), 2009-2013
• Figure 5-6: Global - Clinical Chemistry & Immunochemistry Market (Billion US$), 2009-2013
• Figure 5-7: Global - Share of Players in Molecular Diagnostic Market (2010)
• Figure 5-8: Global - Molecular Diagnostic Market (Billion US$), 2009-2013
• Figure 5-9: Global - Microbiology Diagnostic Market (Billion US$), 2010-2013
• Figure 5-10: Global - Hemostasis Diagnostic Market (Billion US$), 2010-2013
• Figure 5-11: Global - Hematology Market (Billion US$), 2009-2013
• Figure 5-12: Global - Immunohematology Diagnostic Market (Billion US$), 2009-2013
• Figure 6-1: Global - Diabetic Population (Million), 2010 & 2030
• Figure 6-2: Global - Diabetes Diagnostic & Therapies Market (Billion US$), 2009-2013
• Figure 6-3: Global - Cardiovascular Diagnostic and Therapies Market (Billion US$), 2009-2013
• Figure 6-4: Global - Cancer In Vitro Diagnostic Market (Billion US$), 2011-2013
• Figure 6-5: Global - HIV Diagnostic and Monitoring Market (Million US$), 2004, 2008 & 2012
• Figure 6-6: Global - Tuberculosis Diagnostic Market by Segment (%)
• Figure 6-7: Global - Tuberculosis Detection and Monitoring Market by Segment (%)
• Figure 6-8: Global - Influenza Diagnostic Market (Million US$), 2008-2013
• Figure 7-1: Global - In Vitro Diagnostic Market by Region (%), 2010
• Figure 7-2: Global - Forecast for In Vitro Diagnostic Market by Region (%), 2013
• Figure 7-3: US - Labs in IVD Market by Type (%)
• Figure 7-4: US - In Vitro Diagnostic Market (Billion US$), 2008-2013
• Figure 7-5: Canada - In Vitro Diagnostic Market (Billion US$), 2009-2013
• Figure 7-6: Europe - In Vitro Diagnostic Market (Billion Euro), 2009-2013
• Figure 7-7: Europe - In Vitro Diagnostic Market by Country (%), 2009
• Figure 7-8: Germany - In Vitro Diagnostic Market by Clinical Segment (%), 2009
• Figure 7-9: Germany - In Vitro Diagnostic Market (Billion Euro), 2009-2013
• Figure 7-10: France - In Vitro Diagnostic Reagents Market by Clinical Segment (%)
• Figure 7-11: France - In Vitro Diagnostic Market (Billion Euro), 2009-2013
• Figure 7-12: Italy - In Vitro Diagnostic Market by Segment (%), 2008
• Figure 7-13: Italy - In Vitro Diagnostic Reagents Market by Segment (%), 2008
• Figure 7-14: Italy - In Vitro Diagnostic Market (Billion Euro), 2009-2013
• Figure 7-15: UK - In Vitro Diagnostic Market by Clinical Segment (%), 2009
• Figure 7-16: UK - In Vitro Diagnostic Market (Billion Euro), 2009-2013
• Figure 7-17: Spain - In Vitro Diagnostic Market (Billion Euro), 2009-2013
• Figure 7-18: Japan - In Vitro Diagnostic Market by Clinical Segment (%), 2009
• Figure 7-19: Japan - Share of Players in In Vitro Diagnostic Market
• Figure 7-20: Japan - In Vitro Diagnostic Market (Billion Yen), 2009-2013
• Figure 7-21: China - In Vitro Diagnostic Market by Clinical Segment (%), 2009
• Figure 7-22: China - In Vitro Diagnostic Market (Billion US$), 2009-2013
• Figure 7-23: India - In Vitro Diagnostic Market by Clinical Segment (%), 2009
• Figure 7-24: India - In Vitro Diagnostic Market (Million US$), 2009-2013
• Figure 7-25: Turkey - Share of Clinical Laboratories by Type
• Figure 7-26: Turkey - In Vitro Diagnostic Market (Million Euro), 2008-2013
• Figure 7-27: Brazil - In Vitro Diagnostic Market by Clinical Segment (%), 2009
• Figure 7-28: Brazil - In Vitro Diagnostic Market (Million US$), 2009-2013
• Figure 7-29: Mexico - In Vitro Diagnostic Market by Clinical Segment (%)
• Figure 7-30: Mexico - In Vitro Diagnostic Market (Million US$), 2008-2013
• Figure 11-1: Global - R&D Expenditure on IVD in Comparison to Other Industrial Sectors (%)
• Figure 12-1: Global - Share of Players in In Vitro Diagnostic Market
• Figure 12-2: Roche Holding Ltd. - Diagnostic Division Revenues by Segment (%), 2010
• Figure 12-3: Abbott Laboratories - Diagnostic Products Sales (Million US$), 2007-2010
• Figure 12-4: Siemens AG - Diagnostic Division Revenues (Million Euro), FY 2009 & FY 2010
• Figure 12-5: Beckman Coulter - Clinical Diagnostics Revenues by Segment (%), 2010

List of Tables:

• Table 3-1: Commonly Used In Vitro and In Vivo Diagnostic Tests
• Table 5-1: Global - In Vitro Diagnostic Market by Clinical Segment (Billion US$), 2010
• Table 5-2: Global - Forecast for In Vitro Diagnostic Market by Clinical Segment (Billion US$), 2013
• Table 5-3: Global - Share of Top Players in Clinical Chemistry and Immunochemistry Market (2010)
• Table 5-4: Global - Share of Top Players in Microbiology Diagnostic Market (2010)
• Table 5-5: Global - Share of Top Players in Hemostasis Diagnostic Market (2009)
• Table 6-1: Global - Leading Companies in Diabetes Equipment Sales (Billion US$)
• Table 7-1: Other European Countries - In Vitro Diagnostic Market (Million Euro), 2009
• Table 12-1: Roche Holding Ltd. - Strengths & Weaknesses
• Table 12-2: Abbott Laboratories - Strengths & Weaknesses
• Table 12-3: Siemens AG - Strengths & Weaknesses
• Table 12-4: Beckman Coulter - Strengths & Weaknesses
• Table 12-5: Ortho-Clinical Diagnostics - Strengths & Weaknesses

相關商品

體外診斷設備相關市場調查報告書

全球切片設備市場:開發平台分析，競爭環境，到2018年為止的市場預測
Biopsy Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2018
價格 : US $ 3995
出版日期 : 2012年04月

全球分子診斷市場:各國的設施·檢驗數量·銷售額預測
2012 World Molecular Diagnostics Market Overview: Facilities, Test Volumes, and Sales Forecasts by Country
價格 : US $ 1850
出版日期 : 2012年04月

全球微生物測試市場展望：成長機會及業務拓展策略
2012 Microbiology Testing Market Outlook: Growth Opportunities and Strategies
價格 : US $ 28700
出版日期 : 2012年04月

RNCOS E-Services Pvt. Ltd.發行的醫療設備相關市場調查報告書

印度的診斷市場預測(到2015年為止)

Indian Diagnostic Market Outlook to 2015

價格 : US $ 1200

出版日期 : 2012年03月

全球遺傳基因檢驗市場分析

Global Genetic Testing Market Analysis

價格 : US $ 1200

出版日期 : 2012年01月

美國的血糖監測市場分析

US Glucose Monitoring Market Analysis

價格 : US $ 1000

出版日期 : 2011年11月

Email Alert(Email 通知) - 最新市場調查報告書

GII 將每天定期更新最新市場調查報書資訊，選擇您有興趣的市場分類，我們將用Email的方式讓您收到最新訊息!